Colgate-Palmolive (NYSE:CL – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday.
A number of other research firms have also recently weighed in on CL. Wells Fargo & Company cut their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday. Piper Sandler cut their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. Stifel Nicolaus cut Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price target for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. TD Cowen cut their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday. Finally, JPMorgan Chase & Co. increased their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $103.63.
Get Our Latest Research Report on CL
Colgate-Palmolive Stock Down 1.2 %
Insider Buying and Selling
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.34% of the company’s stock.
Institutional Investors Weigh In On Colgate-Palmolive
Several hedge funds have recently bought and sold shares of CL. Reston Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the 3rd quarter valued at $42,000. Capital Performance Advisors LLP acquired a new stake in Colgate-Palmolive during the third quarter valued at $53,000. Prospera Private Wealth LLC purchased a new position in Colgate-Palmolive in the third quarter valued at about $64,000. True Wealth Design LLC increased its position in Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after purchasing an additional 672 shares during the last quarter. Finally, Continuum Advisory LLC raised its stake in shares of Colgate-Palmolive by 93.4% during the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after purchasing an additional 368 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- Using the MarketBeat Dividend Yield Calculator
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- 3 Monster Growth Stocks to Buy Now
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.